Palbociclib and endocrine therapy in fourth line and beyond for hormone receptor-positive HER2-negative advanced breast cancer: The UK compassionate access program experience

被引：0
|
作者：
Battisti, N. M. L.
Kingston, B.
King, J.
Denton, A.
Waters, S.
Sita-Lumsden, A.
Rehman, F.
Stavraka, C.
Kristeleit, H.
Sawyer, E.
Houghton, D.
Davidson, N.
Howell, S.
Choy, J.
Harper, P.
Roylance, R.
Fharat, R.
Mohammed, K.
Ring, A.
Johnston, S.
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Royal Free London NHS Fdn Trust, London, England
[3] East & North Herts NHS Trust, Stevenage, Herts, England
[4] Velindre Canc Ctr, Cardiff, S Glam, Wales
[5] Imperial Coll Healthcare NHS Trust, London, England
[6] Guys & St Thomas NHS Fdn Trust, London, England
[7] Kings Coll London, Sch Canc & Pharmaceut Sci, London, England
[8] Ramsay Hlth Care UK Rivers Hosp, Sawbridgeworth, England
[9] Christie NHS Fdn Trust, Manchester, Lancs, England
[10] LOC Leaders Oncol Care, London, England
[11] Univ Coll London Hosp NHS Fdn Trust, London, England
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P6-18-23
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-18-23
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of palbociclib or ribociclib in the treatment of advanced hormone receptor-positive, HER2-negative breast cancer
    Bingnan Zhang
    Elisa F. Long
    Breast Cancer Research and Treatment, 2019, 175 : 775 - 779
  • [22] Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer
    Di Cosimo, Serena
    Perez-Garcia, Jose Manuel
    Bellet, Meritxell
    Dalenc, Florence
    Gil, Miguel J. Gil
    Ruiz-Borrego, Manuel
    Gavila, Joaquin
    Aguirre, Elena
    Schmid, Peter
    Marme, Frederik
    Gligorov, Joseph
    Schneeweiss, Andreas
    Albanell, Joan
    Zamora, Pilar
    Wheatley, Duncan
    de Duenas, Eduardo Martinez
    Amillano, Kepa
    Shimizu, Eileen
    Sampayo-Cordero, Miguel
    Cortes, Javier
    Llombart-Cussac, Antonio
    BREAST, 2024, 76
  • [23] Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
    Morikawa, Aki
    Henry, N. Lynn
    CLINICAL CANCER RESEARCH, 2015, 21 (16) : 3591 - 3596
  • [24] Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
    Stearns, Vered
    Brufsky, Adam M.
    Verma, Shailendra
    Cotter, Matthew J.
    Lu, Dongrui R.
    Dequen, Florence
    Joy, Anil Abraham
    CLINICAL BREAST CANCER, 2018, 18 (06) : E1239 - E1245
  • [25] Effectiveness and Safety of Palbociclib plus Endocrine Therapy in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Real-World Results
    Fernandez-Cuerva, Cristina
    Valencia, Juan Carlos del Rio
    Tamayo Bermejo, Rocio
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2022, 75 (01): : 26 - 33
  • [26] Effectiveness and Safety of Palbociclib plus Endocrine Therapy in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Real-World Results
    Fernandez-Cuerva, C.
    Del Rio, Valencia J. C.
    Bermejo, R. T.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2022, 75 (02): : 128 - 128
  • [27] Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience
    Pizzuti, Laura
    Giordano, Antonio
    Michelotti, Andrea
    Mazzotta, Marco
    Natoli, Clara
    Gamucci, Teresa
    De Angelis, Claudia
    Landucci, Elisabetta
    Diodati, Lucrezia
    Iezzi, Laura
    Mentuccia, Lucia
    Fabbri, Agnese
    Barba, Maddalena
    Sanguineti, Giuseppe
    Marchetti, Paolo
    Tomao, Silverio
    Mariani, Luciano
    Paris, Ida
    Lorusso, Vito
    Vallarelli, Simona
    Cassano, Alessandra
    Airoldi, Francesca
    Orlandi, Armando
    Moscetti, Luca
    Sergi, Domenico
    Sarobba, Maria Giuseppina
    Tonini, Giuseppe
    Santini, Daniele
    Sini, Valentina
    Veltri, Enzo
    Vaccaro, Angela
    Ferrari, Laura
    De Tursi, Michele
    Tinari, Nicola
    Grassadonia, Antonino
    Greco, Filippo
    Botticelli, Andrea
    La Verde, Nicla
    Zamagni, Claudio
    Rubino, Daniela
    Cortesi, Enrico
    Magri, Valentina
    Pomati, Giulia
    Scagnoli, Simone
    Capomolla, Elisabetta
    Kayal, Ramy
    Scinto, Angelo Fedele
    Corsi, Domenico
    Cazzaniga, Marina
    Laudadio, Lucio
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 7708 - 7717
  • [28] Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
    Ditsch, Nina
    Schmidt, Marcus
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (12) : 1328 - 1335
  • [29] Second-line Endocrine Therapy of Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: A Systematic Review and Network Meta-analysis
    Wang, Tianzhuo
    Shen, Guoshuang
    Li, Jinming
    Huo, Xingfa
    Wang, Miaozhou
    Liu, Zhen
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Jiuda
    CURRENT CANCER DRUG TARGETS, 2023, 23 (09) : 718 - 730
  • [30] Impact of adjuvant endocrine therapy on prognosis in small hormone receptor-positive, HER2-negative early breast cancer
    Yayoi Adachi
    Isao Oze
    Masataka Sawaki
    Masaya Hattori
    Akiyo Yoshimura
    Haruru Kotani
    Ayumi Kataoka
    Kayoko Sugino
    Nanae Horisawa
    Yuri Ozaki
    Yuka Endo
    Kazuki Nozawa
    Daiki Takatsuka
    Hiroji Iwata
    Breast Cancer, 2021, 28 : 1087 - 1095
12345